[Characteristics of secondary immunologic deficiency in children with chronic hepatitis B and the methods of its correction].
Gol'zand. I V IV; Egorov. V B VB; Popova. I A IA
Key Findings
- Children with chronic hepatitis B often show impaired immune cells and produce temperature‑dependent autolymphocytotoxins.
- Thymalin treatment was effective in patients lacking cold autolymphocytotoxins or with low activity of these toxins.
- A combination of decaris and prednisolone helped children who had pronounced cold autolymphocytotoxins, indicating a need for tailored therapy.
Practical Outcomes
- For self‑directed health enthusiasts, thymalin may have immune‑modulating effects, but the benefit appears limited to particular immune profiles seen in chronic hepatitis B. It isn’t a broad‑spectrum anti‑aging or performance enhancer and should only be considered under medical guidance, especially when dealing with viral infections or autoimmune markers.
Summary
The study looked at kids with chronic hepatitis B who also had a weakened immune system. It found that a peptide called thymalin helped improve immune function in some of them, especially those without a certain type of harmful immune factor, while a combo of decaris and prednisolone helped those who did have that factor. The results suggest thymalin can modulate immunity, but only in very specific disease conditions.
Abstract
A study was made of the immune system of patients with chronic HB-viral infection who showed the signs of secondary immundeficiency. The high frequency of the impairment of immunocompetent cells seen in chronic hepatitis B was established as was the appearance of different-temperature autolymphocytotoxins in response to the infection of mono-nuclears in all the disease stages. The treatment with thymalin proved effective in patients with the lack of cold autolymphocytotoxins or in those with low activity of the latter ones. The combined treatment (decaris plus prednisolone) turned out effective in children with a pronounced autoimmune component of the process (the presence of cold autolymphocytotoxins). It has been shown that the discovered interrelations between the different components of the immune system are conductive to the determination of the pathological process type and the choice of adequate therapy.
Study Information
pubmed
1989